Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 118 entries
View as:

Database Study to Provide Information on Pregnancy and Infant Outcomes Among Women Exposed to QUVIVIQ (Daridorexant)

Phase: N/A Priority: Normal
NCT ID: NCT06393504 Org: User:
Start: 11/30/23 End: 04/30/28 Due: 04/30/29

Study to Evaluate Safety and Tolerability of ACT-709478 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03165097 Org: User:
Start: 07/07/17 End: 12/28/18 Due: 12/28/19

A Study to Investigate the Effects of Daridorexant on Nighttime Breathing in Patients With Shallow or Paused Breath During Sleep

Phase: N/A Priority: Normal
NCT ID: NCT05458193 Org: User:
Start: 08/17/22 End: 02/28/23 Due: 02/28/24

A Study to Evaluate ID-085 in People With Mild, Moderate, and Severe Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT03913000 Org: User:
Start: 04/29/19 End: 08/22/19 Due: 08/22/20

Clinical Study to Assess Body Fluid Homeostasis After Administration of ACT-132577 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02708004 Org: User:
Start: 06/01/16 End: 12/01/16 Due: 12/01/17

Tezosentan in Acute Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT00525707 Org: User:
Start: 04/30/03 End: 01/31/05 Due: 01/31/06

Study of ACT-129968 in Adult Patients With Seasonal Allergic Rhinitis

Phase: N/A Priority: Normal
NCT ID: NCT01241214 Org: User:
Start: 11/30/10 End: 02/28/11 Due: 02/28/12

A Study to Evaluate the Pharmacokinetics of ACT-541468 in Subjects With Mild, Moderate, and Severe Hepatic Impairment

Phase: N/A Priority: Normal
NCT ID: NCT03713242 Org: User:
Start: 02/26/18 End: 02/27/20 Due: 02/27/21

A Study to Investigate the Drug-drug Interactions Between ACT-541468 and Ethanol in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03609775 Org: User:
Start: 08/28/18 End: 10/09/18 Due: 10/09/19

A Study to Investigate the Effect of Single and Repeated Oral Doses of ACT-539313 on What the Body Does to Flurbiprofen, Omeprazole, Midazolam in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05254548 Org: User:
Start: 02/18/22 End: 04/13/22 Due: 04/13/23

A Study in Healthy Male Subjects to Investigate the Effect of Famotidine and Efavirenz on the Way the Body Takes up, Distributes, and Gets Rid of Daridorexant.

Phase: N/A Priority: Normal
NCT ID: NCT04390334 Org: User:
Start: 05/13/20 End: 06/26/20 Due: 06/26/21

A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Heart Attack

Phase: N/A Priority: Normal
NCT ID: NCT03487445 Org: User:
Start: 07/10/18 End: 11/10/18 Due: 11/10/19

A Study to Investigate the Pharmacokinetics of ACT-1014-6470 in Subjects With Severe Renal Impairment Compared to Control Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04899219 Org: User:
Start: 06/16/21 End: 11/12/21 Due: 11/12/22

Dose-finding Study Assessing the Efficacy, Safety, and Pharmacokinetics of Daridorexant in Subjects Aged 10 to < 18 Years With Insomnia Disorder

Phase: N/A Priority: Normal
NCT ID: NCT05423717 Org: User:
Start: 08/09/22 End: 04/30/26 Due: 04/30/27

A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and Find Out More About Its Safety

Phase: N/A Priority: Normal
NCT ID: NCT03541174 Org: User:
Start: 06/18/18 End: 04/25/22 Due: 04/25/23

Clazosentan in Preventing the Occurrence of Cerebral Vasospasm Following an Aneurysmal Subarachnoid Hemorrhage (aSAH)

Phase: N/A Priority: Normal
NCT ID: NCT00111085 Org: User:
Start: 01/10/05 End: 03/30/06 Due: 03/30/07

Clinical Research Study With Clazosentan to Evaluate Its Effects on Preventing Complications Due to the Narrowing of the Blood Vessels (Vasospasm) in the Brain, Caused by Bleeding Onto the Surface of the Brain

Phase: N/A Priority: Normal
NCT ID: NCT03585270 Org: User:
Start: 02/03/19 End: 11/18/22 Due: 11/18/23

A Study to Assess the Safety, Tolerability and Pharmacokinetics of Lucerastat (CDP923) After Multiple Dosing in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02944474 Org: User:
Start: 12/31/03 End: 05/31/04 Due: 05/31/05

Efficacy, Safety, and Tolerability Study of ACT-129968 in Patients With Seasonal Allergic Rhinitis

Phase: N/A Priority: Normal
NCT ID: NCT01484119 Org: User:
Start: 12/31/11 End: 03/31/12 Due: 03/31/13

Efficacy and Safety of ACT-541468 in Adult Subjects With Insomnia Disorder

Phase: N/A Priority: Normal
NCT ID: NCT02839200 Org: User:
Start: 10/04/16 End: 06/20/17 Due: 06/20/18

First-in-man Study of Single Ascending Dose of a New Drug for Neurological Disorders

Phase: N/A Priority: Normal
NCT ID: NCT02719197 Org: User:
Start: 02/19/16 End: 12/01/16 Due: 12/01/17

A Study in Healthy Male Subjects to Investigate Whether Administration of ACT-541468 Can Affect the Fate in the Body (Amount and Time of Presence in the Blood) of Rosuvastatin

Phase: N/A Priority: Normal
NCT ID: NCT03339752 Org: User:
Start: 10/30/17 End: 12/02/17 Due: 12/02/18

Efficacy and Safety of Lucerastat Oral Monotherapy in Adult Subjects With Fabry Disease

Phase: N/A Priority: Normal
NCT ID: NCT03425539 Org: User:
Start: 06/21/18 End: 09/02/21 Due: 09/02/22

A Research Study to Show Aprocitentan is Efficacious and Safe to Treat Patients With Uncontrolled Blood Pressure and Chronic Kidney Disease.

Phase: N/A Priority: Normal
NCT ID: NCT04162366 Org: User:
Start: 01/31/20 End: 07/15/21 Due: 07/15/22

Long-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT06475742 Org: User:
Start: 07/30/24 End: 05/31/28 Due: 05/31/29